Black Raspberry Extracts Inhibit Benzo(A)Pyrene Diol-Epoxide-Induced Activator Protein 1 Activation And Vegf Transcription By Targeting The Phosphotidylinositol 3-Kinase/Akt Pathway

Chuanshu Huang,Jingxia Li,Lun Song,Dongyun Zhang,Qiangsong Tong,Min Ding,Linda Bowman,Robeena Aziz,Gary D Stoner

DOI: https://doi.org/10.1158/0008-5472.CAN-05-1951

IF: 11.2

2006-01-01

Cancer Research

Abstract:Previous studies have shown that freeze-dried black raspberry extract fractions inhibit benzo(alpha)pyrene [B(alpha)P]-induced transformation of Syrian hamster embryo cells and benzo(alpha)pyrene diol-epoxide [B(alpha)PDE] -induced activator protein-1 (AP-1) activity in mouse epidermal Cl 41 cells. The phosphotidylinositol 3-kinase (PI-3K)/Akt pathway is critical for B(alpha)PDE-induced AP-1 activation in mouse epidermal Cl 41 cells. In the present study, we determined the potential involvement of PI-3K and its downstream kinases on the inhibition of AP-1 activation by black raspberry fractions, RO-F003, RO-F004, RO-ME, and RO-DM. In addition, we investigated the effects of these fractions on the expression of the AP-1 target genes, vascular endothelial growth factor (VEGF) and inducible nitric oxide synthase (iNOS). Pretreatment of Cl 41 cells with fractions RO-F003 and RO-ME reduced activation of AP-1 and the expression of VEGF, but not iNOS. In contrast, fractions RO-F004 and RO-DM had no effect on AP-1 activation or the expression of either VEGF or iNOS. Consistent with inhibition of AP-1 activation, the RO-ME fraction markedly inhibited activation of PI-3K, Akt, and p70 S6 kinase (p70(S6k)). In addition, overexpression of the dominant negative PI-3K mutant Delta p85 reduced the induction of VEGF by B(a)PDE. It is likely that the inhibitory effects of fractions RO-F003 and RO-ME on B(a)PDE-induced AP-1 activation and VEGF expression are mediated by inhibition of the PI-3K/Akt pathway. In view of the important roles of AP-1 and VEGF in tumor development, one mechanism for the chemopreventive activity of black raspberries may be inhibition of the PI-3K/Akt/AP-I/VEGF pathway.